Changing Trends in the Proportional Incidence and Five-year Net Survival of Screened and Non-screened Breast Cancers among Women During 1995–2011 in England
Journal of Clinical and Translational Pathology · 2022
DOI: 10.14218/jctp.2022.00003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Translational Pathology, 2022. Verfasst von Haiyan Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Data Research UK London, UCL Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, UK. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background and objectives: Uptake of breast cancer screening has been decreasing in England since 2007. However, the associated factors are unclear. On the other hand, survival among breast cancer patients have recently increased. We conducted a quasi-experimental analysis to test whether the trend-change in proportional incidence of non-screened cancers coincided with that in five-year net-survival.
Methods
We extracted population-based proportional incidence and age-standardized five-year net-survival data from Public Health England that included English women with invasive breast cancer diagnosed during 1995-2011 (linked to death certificates, followed through 2016). Piece-wise log-linear models with change-point/joinpoint were used to estimate temporal trends.
Results
Among 254,063 women in England with invasive breast cancer diagnosed during 1995-2011, there was downward-to-upward trend-change in proportional incidence of non-screened breast cancers (annual percent change [APC]=5.6 after 2007 versus APC=-3.5 before 2007, p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Data Research UK London, UCL Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, UK.
- National Cancer Registration and Analysis Service, Public Health England, Birmingham B3 2PW, UK.
- Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
- Department of Biostatistics, School of Public Health, Rutgers University, Piscataway, NJ, USA.
- Department of Pathology, Princeton Medical Center, Plainsboro, NJ, USA.
- Department of Biological Sciences, Rutgers University, Newark, NJ, USA.
ORCID-Profile: Lanjing Zhang
Förderung
- NCI NIH HHS
Zitieren
APA
Wu, H., Wong, K., Lu, S. E., Broggio, J., & Zhang, L. (2022). Changing Trends in the Proportional Incidence and Five-year Net Survival of Screened and Non-screened Breast Cancers among Women During 1995–2011 in England. Journal of Clinical and Translational Pathology. https://doi.org/10.14218/jctp.2022.00003
Vancouver
Wu H, Wong K, Lu SE, Broggio J, Zhang L. Changing Trends in the Proportional Incidence and Five-year Net Survival of Screened and Non-screened Breast Cancers among Women During 1995–2011 in England. Journal of Clinical and Translational Pathology. 2022. doi:10.14218/jctp.2022.00003
BibTeX
@article{Wu2022,
author = {Wu, Haiyan and Wong, Kwok and Lu, Shou-En and Broggio, John and Zhang, Lanjing},
title = {Changing Trends in the Proportional Incidence and Five-year Net Survival of Screened and Non-screened Breast Cancers among Women During 1995–2011 in England},
journal = {Journal of Clinical and Translational Pathology},
year = {2022},
doi = {10.14218/jctp.2022.00003}
}
EUVIMED